FDA Drug Application (203148) for RIVASTIGMINE TARTRATE by MACLEODS PHARMS LTD

Back to FDA Applications sponsored by MACLEODS PHARMS LTD

Application Number203148
Product Number001
FormCAPSULE;ORAL
DosageEQ 1.5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameRIVASTIGMINE TARTRATE
Active IngredientRIVASTIGMINE TARTRATE



Back to FDA Applications sponsored by MACLEODS PHARMS LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.